During the past decade, Centre Hospitalier François Quesnay conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier François Quesnay" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 5 trials, followed by "ANRS, Emerging Infectious Diseases" with 3 trials sponsored, "Centre Hospitalier Annecy Genevois" with 1 trials sponsored, "Centre Hospitalier Departemental Vendee" with 1 trials sponsored and "Dr Christophe LENCLUD" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier François Quesnay" #1 collaborator was "Ministry of Health, France" with 1 trials as a collaborator, "URC Eco Ile de France" with 1 trials as a collaborator, "University Hospital, Grenoble" with 1 trials as a collaborator and "University Hospital, Tours" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier François Quesnay" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "ALK Gene Mutation" (1 trials), "ARDS, Human" (1 trials), "Advanced Non Small Cell Lung Cancer" (1 trials) and "BRAF Gene Mutation" (1 trials). Many other conditions were trialed in "Centre Hospitalier François Quesnay" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier François Quesnay" are "Drug" (7 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antiretroviral" (1 trials), "Bevacizumab" (1 trials), "Chemotherapy" (1 trials), "Customized Treatment" (1 trials) and "Data collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier François Quesnay" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier François Quesnay". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Centre Hospitalier François Quesnay, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier François Quesnay, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".